Patients with advanced pancreatic cancer benefit from Abraxane (nab-paclitaxel)

By all measures, the addition of nab-paclitaxel for the treatment of patients with advanced pancreatic cancer was superior to the survival for patients who received only gemcitabine, according to the results of a study led by the Translational Genomics Research Institute (TGen) and Scottsdale Healthcare, published by The New England Journal of Medicine...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Pancreatic Cancer Source Type: news